| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 9, 2015Data Presented at AHA and Simultaneously Published in the New England Journal of Medicine Demonstrate High Implant Success and Reduced Healthcare Utilization
DUBLIN and ORLANDO - Nov. 9, 2015 - In the largest clinical data presentation ever of transcatheter pacing patients, Medtronic plc (NYSE: MDT) today announced that the Medtronic Micra®...
-
Nov 9, 2015New, Innovative Technology Brings Relief to Patients Suffering with Varicose Veins
DUBLIN - November 9, 2015 - Medtronic plc (NYSE: MDT) today announced U.S. availability of the VenaSeal(TM) closure system, the first and only non-tumescent, non-thermal, non-sclerosant procedure...
-
Nov 6, 2015
DUBLIN - Nov. 6, 2015 - Medtronic plc (NYSE: MDT) announced today it will report financial results for the second quarter of its fiscal year 2016 on Thursday, December 3, 2015. A news release will...
-
Nov 6, 2015
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Nov 5, 2015"Further, Together" Showcases the Company's Economic, Social and Environmental Performance in Fiscal Year 2015
DUBLIN - November 5, 2015 - Medtronic plc (NYSE:MDT) announces the release of its 2015 Integrated Performance Report, "Further, Together", which provides a compelling, comprehensive view of how...
-
Nov 5, 2015World's Smallest Pacemaker and Investigational Insulin Pump System Recognized Among the Top 100 Technology Innovations
DUBLIN - November 18, 2015 - Medtronic plc (NYSE: MDT) today announced that its Micra® Transcatheter Pacing System (TPS) and Hybrid Closed Loop system have both earned the 2015 'Best of What's...
-
Nov 3, 2015
HeartWare International, Inc. (Nasdaq: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Nov 2, 2015Health-Economic Analysis Demonstrates Medtronic IN.PACT Admiral Drug-Coated Balloon Is Cost-Effective Compared to Standard PTA; Global Study Data Demonstrates Strong Clinical Outcomes in Patients with In-Stent Restenosis
DUBLIN and LAS VEGAS - Nov. 2, 2015 - Medtronic plc (NYSE: MDT) adds to the robust data for its IN.PACT® Admiral® drug-coated balloon (DCB) with the presentation of both its formal...
-
Nov 2, 2015Medtronic Unveils New Aortic and Peripheral Data from Two Late-Breaking Clinical Trials at VIVA 2015Meeting Highlights New Two-Year Data with Valiant Thoracic Stent Graft in Type B Aortic Dissection and Nine-Month Comparison Data in Leading Treatments for Peripheral Iliac Artery Disease
DUBLIN and LAS VEGAS - Nov. 2, 2015 - Medtronic plc (NYSE: MDT) today announced new clinical data in interventional treatments for aortic and peripheral vascular diseases in a late-breaking trial...
-
Nov 2, 2015VIVA Physician Sponsored Study to Determine the Benefits of Debulking Plaque and Maximizing Luminal Gain Prior to Drug Coated Balloon Therapy
DUBLIN and LAS VEGAS - Nov. 2, 2015 - Medtronic plc (NYSE: MDT) announced today the initiation of the REALITY Study (DiRectional AthErectomy + Drug-coAted BaLloon to Treat Long, Calcified...